HIND vs PATH · rev $8.0M vs P/E 19, rev $1.61B
Vyome Holdings, Inc. (HIND) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Vyome Holdings, Inc. (HIND) is a biotechnology company listed on NASDAQ.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported HIND revenue for 2024-12-31 was $8.0M. Net income was -$7.1M. Revenue was down 7.7% from 2023-12-31 to 2024-12-31. HIND currently screens at market cap $16.1M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
HIND currently screens at market cap $16.1M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the HIND and PATH stock pages for the full models.
Not investment advice.